Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204


Become EABM
Become Reviewer

Energy Dependent Transport of Xenobiotics and Its Relevance to Multidrug Resistance

Volume:3   Issue: 2
Pp: 89-107
Rajendra Sharma, Yogesh C. Awasthi, Yusong Yang, Abha Sharma, Sharad S. Singhal and Sanjay Awasthi
DOI: 10.2174/1568009033482047

Increasing Complexity of Farnesyltransferase Inhibitors Activity: Role in Chromosome Instability

Volume:3   Issue: 2
Pp: 109-118
Carla Falugi, Sonya Trombino, Pierluigi Granone, Stefano Margaritora and Patrizia Russo
DOI: 10.2174/1568009033482056

Phage Display Selection and Evaluation of Cancer Drug Targets

Volume:3   Issue: 2
Pp: 119-129
Victor I. Romanov
DOI: 10.2174/1568009033482010

Survivin: Role in Normal Cells and in Pathological Conditions

Volume:3   Issue: 2
Pp: 131-152
L. O'Driscoll, R. Linehan and M. Clynes
DOI: 10.2174/1568009033482038

Induction of Senescent-Like Growth Arrest as a New Target in Anticancer Treatment

Volume:3   Issue: 2
Pp: 153-159
Xianghong Wang, Sai-Wah Tsao, Yong-Chuan Wong and Annie L.M. Cheung
DOI: 10.2174/1568009033482001

Erratum promotion: free to download

Volume:3   Issue: 2
Pp: 161-161

DOI: 10.2174/1568009033482029